The endocrine oncology research group @matthiaskroiss is seeking a motivated PhD student for a hot 🔥🔬🧬research topic in @adrenalresearch
Send us a message or email [email protected] for more details!
Now online: @WeigandIsabel @landwehr_laura Jochen Schreiner @EJEndo@ESEndocrinology: A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden https://t.co/VaXuIwgvZG
Excited to see this finally online. Thanks to everyone who contributed! @DavideCalebiro@CryRonchi@matthiaskroiss@EndoWue@Uni_WUE
PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser114 phosphorylation https://t.co/IaVjLcXOkM
Breakthrough therapy for advanced medullary thyroid cancer harboring RET mutation. Congratulations to all the researchers including @matthiaskroiss@Uni_WUE
and thanks to all the patients and their families
https://t.co/ljzWDh48KF
Our contribution to cancer predisposition associated with the TP53 R337H mutation widespread in Brazil is highlighted in Science Advances page. Most of carriers also harbor a mutation in XAF1 and the presence of both mutated alleles increases cancer risk @StJudeResearch@StJude.
Sadly, but with the health and safety of all our members in mind, #ECE2020 is being delayed until later this year. Please read President Andrea Giustina's statement for more information. @ESEndocrinology@EYEScientists https://t.co/G50PoH45dJ
What a wonderful way to end great #ACC2019Clermont. Perfect day hike up Puy de Dôme in Auvergne, France with Würzburg adrenophylics - Isabel Weigand and Laura-Sophie Landwehr. Thanks for the company and perspectives. Onward and Upward all. @TheEndoSociety@UMRogelCancer
Interesting data from the European Network for the Study of Adrenal Tumors on individual prognostic assessment in adrenocortical carcinoma: “Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma”. #ENSAT https://t.co/0HJz0iBFbD